Epidermal growth factor receptor (EGFR) nuclear translocation correlates with the abnormal proliferation, migration, and anti-apoptosis of tumor cells. Monitoring EGFR nuclear translocation provides insights into the molecular mechanisms underlying cancers. EGFR nuclear translocation includes two processes, EGFR phosphorylation and phosphorylated EGFR translocation to the nucleus. With the help of aptamers, probes that can achieve the first step of anchoring phosphorylated EGFR have been developed. However, the EGFR nuclear translocation can last for hours, posing a challenge to monitor the entire nuclear translocation in living cells. Herein, we designed a circular bivalent aptamer-functionalized optical probe with greatly enhanced stabili...
Nuclear transport of epidermal growth factor receptor (EGFR) is considered to be a key cause of radi...
Na Li is with AM Biotechnologies, Hong Hanh Nguyen is with University of California Los Angeles, Mic...
Aptamers continue to receive interest as potential therapeutic agents for the treatment of diseases,...
Abstract Tumor cells depict two deviant tendencies; over-proliferation and vigorous migration. A tap...
Emerging evidence suggests the existence of a new mode of epidermal growth factor receptor (EGFR) si...
Abstract Circulating tumor cell detection is one impor-tant avenue for early cancer diagnosis. A dif...
Glioblastoma (GBM) is the most frequent and aggressive primary adult brain tumor with poor prognosis...
AbstractThe epidermal growth factor (EGF) transduces its actions via the EGF receptor (EGFR), which ...
Epidermal growth factor receptor (EGFR) is a transmembrane tyrosine kinase receptor, which is overex...
Despite decades of research in the epidermal growth factor receptor (EGFR) signalling field, and man...
Despite decades of research in the epidermal growth factor receptor (EGFR) signalling field, and man...
International audienceNucleic-acid aptamers are of strong interest for diagnosis and therapy. Compar...
Sequestration within the cytoplasm often limits the efficacy of therapeutic nanoparticles that have ...
Awealth of research has focused on developing targeted cancer therapies by specifically inhibiting e...
Awealth of research has focused on developing targeted cancer therapies by specifically inhibiting e...
Nuclear transport of epidermal growth factor receptor (EGFR) is considered to be a key cause of radi...
Na Li is with AM Biotechnologies, Hong Hanh Nguyen is with University of California Los Angeles, Mic...
Aptamers continue to receive interest as potential therapeutic agents for the treatment of diseases,...
Abstract Tumor cells depict two deviant tendencies; over-proliferation and vigorous migration. A tap...
Emerging evidence suggests the existence of a new mode of epidermal growth factor receptor (EGFR) si...
Abstract Circulating tumor cell detection is one impor-tant avenue for early cancer diagnosis. A dif...
Glioblastoma (GBM) is the most frequent and aggressive primary adult brain tumor with poor prognosis...
AbstractThe epidermal growth factor (EGF) transduces its actions via the EGF receptor (EGFR), which ...
Epidermal growth factor receptor (EGFR) is a transmembrane tyrosine kinase receptor, which is overex...
Despite decades of research in the epidermal growth factor receptor (EGFR) signalling field, and man...
Despite decades of research in the epidermal growth factor receptor (EGFR) signalling field, and man...
International audienceNucleic-acid aptamers are of strong interest for diagnosis and therapy. Compar...
Sequestration within the cytoplasm often limits the efficacy of therapeutic nanoparticles that have ...
Awealth of research has focused on developing targeted cancer therapies by specifically inhibiting e...
Awealth of research has focused on developing targeted cancer therapies by specifically inhibiting e...
Nuclear transport of epidermal growth factor receptor (EGFR) is considered to be a key cause of radi...
Na Li is with AM Biotechnologies, Hong Hanh Nguyen is with University of California Los Angeles, Mic...
Aptamers continue to receive interest as potential therapeutic agents for the treatment of diseases,...